Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

N Reguart, AF Cardona, R Rosell - Cancer management and …, 2010 - Taylor & Francis
Erlotinib hydrochloride (Tarceva®) is a member of a class of small molecule inhibitors that
targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with anti …
被引用次数：35 相关文章

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer.

N Reguart, AF Cardona, R Rosell - Cancer Management and …, 2010 - europepmc.org
Erlotinib hydrochloride (Tarceva®) is a member of a class of small molecule inhibitors that
targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with anti …
[PDF] researchgate.net

[PDF][PDF] Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

N Reguart - Cancer Management and Research, 2010 - researchgate.net
Erlotinib hydrochloride (Tarceva) is a member of a class of small molecule inhibitors that
targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with anti …
[PDF] semanticscholar.org

[PDF][PDF] Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

N Reguart - Cancer Management and Research, 2010 - pdfs.semanticscholar.org
Erlotinib hydrochloride (Tarceva) is a member of a class of small molecule inhibitors that
targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with anti …

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

N Reguart, AF Cardona, R Rosell - Cancer Management and Research, 2010 - inis.iaea.org
[en] Erlotinib hydrochloride (Tarceva"®) is a member of a class of small molecule inhibitors
that targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with …
[HTML] nih.gov

[HTML][HTML] Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

N Reguart, AF Cardona, R Rosell - Cancer management and …, 2010 - ncbi.nlm.nih.gov
Erlotinib hydrochloride (Tarceva®) is a member of a class of small molecule inhibitors that
targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with anti …
[PDF] academia.edu

[PDF][PDF] Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

N Reguart - Cancer Management and Research, 2010 - academia.edu
Erlotinib hydrochloride (Tarceva) is a member of a class of small molecule inhibitors that
targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with anti …

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

N Reguart, AF Cardona… - Cancer management …, 2010 - pubmed.ncbi.nlm.nih.gov
Erlotinib hydrochloride (Tarceva (®)) is a member of a class of small molecule inhibitors that
targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with anti …

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

N Reguart, AF Cardona, R Rosell - Cancer Management and Research, 2010 - osti.gov
Erlotinib hydrochloride (Tarceva {sup®}) is a member of a class of small molecule inhibitors
that targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with …
[PDF] archive.org

[PDF][PDF] Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

N Reguart - Cancer Management and Research, 2010 - scholar.archive.org
Erlotinib hydrochloride (Tarceva) is a member of a class of small molecule inhibitors that
targets the tyrosine kinase domain of the epidermal growth factor receptor (EGFR), with anti …